IP Library › Granted Patent US 9,856,285
Granted Patent B2
US 9,856,285 · App. 14/660,489 · Granted Jan 2, 2018

Reagents for universal site-specific labeling and modifications of nucleic acids

Inventors: Tzu-Pin Wang (Tainan, TW); Yu-Chih Su (Tainan, TW)
Assignee: KAOHSIUNG MEDICAL UNIVERSITY
C07H21/02C07H1/00C07H21/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,856,285
App. No.
14/660,489
Granted
Jan 2, 2018
Kind
B2
Abstract

The present invention discloses a method of harnessing versatile phosphoramidation reactions to regioselectively link a group of alkynyl-/azido-containing compounds to post-synthetic nucleic acids primed with phosphate at the 5′ termini. The method includes steps of: (a) monophosphoramidating H 2 N(CH 2 ) n NH 2 to the 5′ end of the nucleic acid to form an intermediate 1 where n is an integer from 2 to 6, and the intermediate 1 has a formula of: (b) amidating the free —NH 2 group of the intermediate 1 with to form an intermediate 2; and (c) reacting the terminal —N 3 group of the intermediate 2 with 1-{3-{[4-(2-cyclooctyn-1-ylmethyl)benzoyl]amino}propyl}-4-{2-[4-(dimethylamino)phenyl]ethenyl}pyridinium hexafluorophosphate (Alkyne MegaStokes dye 608) by the SPAAC reaction to form modified nucleic acids. Without the presence of Cu(I), the modified nucleic acids were subjected to azide-alkyne cycloaddition in an aqueous solution to obtain various nucleic acid conjugates with a high yield.

Claims (7)

1. A method for modifying a nucleic acid molecule, comprising:

(a) monophosphoramidating H 2 N(CH 2 ) n NH 2 to the 5′ end of the nucleic acid to form a conjugated product, wherein n is an integer from 2 to 6, and the conjugated product has a formula of:

(b) amidating the free —NH 2 group of the conjugated product by contacting with R 1 —N 3 , wherein R 1 —N 3 is

R 3 is —(CH 2 ) m —, and m is an integer from 2 to 5; and

(c) reacting the terminal —N 3 group with a cyclooctyne.

2. The method of claim 1 , wherein the cyclooctyne is 1-{3-{[4-(2-cyclooctyn-1-ylmethyl)benzoyl]amino}propyl}-4-{2-[4-(dimethylamino)phenyl]ethenyl}pyridinium hexafluorophosphate.

3. The method of claim 1 , wherein the reacting step is a strain-promoted azide-alkyne cycloaddition reaction.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2015
From: WANG, TZU-PIN; SU, YU-CHIH
To: KAOHSIUNG MEDICAL UNIVERSITY
Reel/Frame 035184/0686 →
Continuity (1)
Related Publication 20160272669A1 · Sep 22, 2016